Mirova US LLC lowered its stake in shares of Xylem Inc. (NYSE:XYL - Free Report) by 2.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,841,615 shares of the industrial products company's stock after selling 54,551 shares during the quarter. Xylem makes up approximately 2.6% of Mirova US LLC's holdings, making the stock its 16th biggest holding. Mirova US LLC owned about 0.76% of Xylem worth $213,664,000 as of its most recent SEC filing.
A number of other hedge funds have also recently added to or reduced their stakes in the stock. Rialto Wealth Management LLC bought a new position in shares of Xylem in the 4th quarter valued at about $31,000. Heck Capital Advisors LLC bought a new position in shares of Xylem in the 4th quarter valued at about $36,000. SRS Capital Advisors Inc. boosted its stake in shares of Xylem by 69.5% in the 4th quarter. SRS Capital Advisors Inc. now owns 317 shares of the industrial products company's stock valued at $37,000 after purchasing an additional 130 shares during the last quarter. Pathway Financial Advisers LLC boosted its stake in shares of Xylem by 122.4% in the 4th quarter. Pathway Financial Advisers LLC now owns 318 shares of the industrial products company's stock valued at $37,000 after purchasing an additional 175 shares during the last quarter. Finally, Assetmark Inc. boosted its stake in shares of Xylem by 3,887.5% in the 3rd quarter. Assetmark Inc. now owns 319 shares of the industrial products company's stock valued at $43,000 after purchasing an additional 311 shares during the last quarter. Institutional investors own 87.96% of the company's stock.
Xylem Stock Down 1.3 %
XYL stock traded down $1.57 during mid-day trading on Friday, hitting $118.27. 2,663,468 shares of the company were exchanged, compared to its average volume of 1,221,711. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.33 and a current ratio of 1.76. The firm has a market cap of $28.75 billion, a P/E ratio of 32.31, a P/E/G ratio of 2.33 and a beta of 1.08. The firm's 50 day simple moving average is $125.24 and its 200 day simple moving average is $126.15. Xylem Inc. has a 1-year low of $113.26 and a 1-year high of $146.08.
Xylem (NYSE:XYL - Get Free Report) last announced its earnings results on Tuesday, February 4th. The industrial products company reported $1.18 EPS for the quarter, topping the consensus estimate of $1.12 by $0.06. Xylem had a net margin of 10.40% and a return on equity of 9.96%. The firm had revenue of $2.30 billion for the quarter, compared to the consensus estimate of $2.18 billion. During the same period last year, the company posted $0.99 EPS. The business's quarterly revenue was up 8.6% on a year-over-year basis. On average, sell-side analysts predict that Xylem Inc. will post 4.65 EPS for the current fiscal year.
Xylem Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 19th. Stockholders of record on Tuesday, February 18th were issued a $0.40 dividend. The ex-dividend date of this dividend was Tuesday, February 18th. This is an increase from Xylem's previous quarterly dividend of $0.36. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.35%. Xylem's dividend payout ratio (DPR) is 43.72%.
Wall Street Analyst Weigh In
Several research analysts have recently issued reports on XYL shares. Wolfe Research reaffirmed a "peer perform" rating on shares of Xylem in a research note on Thursday, December 12th. Stifel Nicolaus reduced their price objective on shares of Xylem from $166.00 to $150.00 and set a "buy" rating on the stock in a research note on Friday, January 24th. Robert W. Baird lifted their price objective on shares of Xylem from $139.00 to $148.00 and gave the stock an "outperform" rating in a research note on Wednesday, February 5th. Finally, Citigroup lowered shares of Xylem from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 5th. Four investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $149.89.
Read Our Latest Stock Analysis on Xylem
Xylem Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Recommended Stories

Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.